Skip to content

Ayurvedic management of oligospermia

Efficacy of Kaunchadi Granules in Ksheena Shukra W.S.R. to Oligospermia - An Open Labelled Randomized Standard Control Clinical Trail - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081283
Enrollment
15
Registered
2025-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to participate in study for 3 months with monthly follow up,Patient having sperm concentration less than 15 million/ml,Patient having sperm concentration along with decreased motility less than 50% & abnormal morphology and volume,Patient having normal thyroid function,Patient with or without clinical presentation of Ksheena Shukra like Daurbalya, Mukhashosha.

Exclusion criteria

Exclusion criteria: Patient suffering from primary or secondary Azoospermia or Aspermia,Patient having history of Male reproductive accessory gland infection, varicocele,Patient having history of previous scrotal or inguinal surgery,Patient having history of Testicular torsion, cryptorchidism,Penile trauma or Penis fracture (rupture of corpus cavernosum),Traumatic and non- traumatic spinal disorders,Patient Taking Cytotoxic drugs, alpha-blockers and spironolactone,Genetic disorders like Klinefelter syndrome,Patient taking treatment for major psychiatric illness,Patient known case of Hypertension (BP more than150/90 mmHg) and Diabetes mellitus (RBS more than 140 mg/dl), COPD, CKD, cardiac diseases, liver diseases, and Chronic Sinusitis,Patient known case of sexually transmitted diseases like Syphilis, Gonorrhea, HIV/AIDS.

Design outcomes

Primary

MeasureTime frame
To improvement in parameters of Semen AnalysisTimepoint: 12 weeks

Secondary

MeasureTime frame
Changes in Hormonal Assay. To improvement in the quality of life & in score of IEEF QuestionnaireTimepoint: 90 days

Countries

India

Contacts

Public ContactVd Grishma Solanki

Institute of Teaching and Research in Ayurveda Jamnagar

grishmabams@gmail.com9427753900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026